RBC Capital analyst Gregory Renza maintained a Buy rating on Amgen (AMGN – Research Report) yesterday and set a price target of $320.00. The ...

RBC Capital analyst Kenneth Herbert maintained a Buy rating on Transdigm Group (TDG – Research Report) yesterday and set a price target of ...

Despite the stronger-than-expected Q1 performance, Compass has maintained its full-year guidance of OSG above 7.5%, while ...

RBC, Jefferies and BNP Paribas are well placed to make gains as HSBC retrenches after Deutsche Numis shows momentum ...

Markets sold off on Monday as investors digested Donald Trump's tariff announcements on Mexico, Canada and China.

Find insight on BNP Paribas, UBS, Kasikornbank and more in the latest Market Talks covering Financial Services.

PennyMac Mortgage Investment Trust (NYSE: PMT) (the "Company" or "PMT") today announced that it is commencing an underwritten public offering of senior notes due 2030 (the "Notes"). The Notes will be ...

RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...

IBM's was the standout deal of the week — Reverse Yankee or otherwise in the single currency. The issuer priced a €3.5bn ...

Since Palantir reported results, Yahoo Finance data shows there have been several upward revisions to EPS expectations for ...